LP185667-5PrulifloxacinActive
Description
LP185667-5 Prulifloxacin
Prulifloxacin is an oral, broad spectrum fluoroquinolone antimicrobial drug. It is metabolized to ulifloxacin, its active form, by first pass metabolism in the liver. It is effective against both gram positive and gram negative bacteria, and indications for use include urinary tract infection and exacerbation of chronic bronchitis. [PMID:18044063]
Source: Regenstrief LOINC, PMID: 18044063
Basic Part Properties
- Name
- Prulifloxacin
- Type
- Component
- Created On
- 2014-07-27
- Construct for LOINC Short Name
- Prulifloxacin
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP185667-5
Language Variants Get Info
- zh-CNChinese (China)
- 普卢沙星
Synonyms: 普卢利沙星;普利沙星; 喹诺酮类抗菌药; 鲁丽沙星; Prulifloxacin; NM-441; 6-Fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1,3thiazer0[3,2-a]quinoline-3-carboxylic acid; CAS 123447-62-1 - nl-NLDutch (Netherlands)
- prulifloxacine
- fr-CAFrench (Canada)
- Prulifloxacine
- it-ITItalian (Italy)
- Prulifloxacina
- es-ESSpanish (Spain)
- Prulifloxacina
- tr-TRTurkish (Turkey)
- Prulifloksasin
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright